Ottenhausen M, Ntoulias G, Bodhinayake I et al (2019) Intradural spinal tumors in adults-update on management and outcome. Neurosurg Rev 42:371–388
Torp SH, Solheim O, Skjulsvik AJ (2022) The WHO 2021 classification of central nervous system tumours: a practical update on what neurosurgeons need to know-a minireview. Acta Neurochir (Wien) 164:2453–2464
Belakhoua SM, Rodriguez FJ (2021) Diagnostic pathology of tumors of peripheral nerve. Neurosurgery 88:443–456
Article PubMed PubMed Central Google Scholar
Agaimy A, Michal M, Abdelsatir A et al (2025) TFE3 -rearranged head and neck neoplasms : twenty-two cases spanning the morphologic continuum between alveolar soft part sarcoma and pecoma and highlighting genotypic diversity. Am J Surg Pathol 49:104–112
Calio A, Brunelli M, Gobbo S et al (2021) Cathepsin K: a novel diagnostic and predictive biomarker for renal tumors. Cancers (Basel). https://doi.org/10.3390/cancers13102441
Ladanyi M, Lui MY, Antonescu CR et al (2001) The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 20:48–57
Article CAS PubMed Google Scholar
Randazzo MJ, Thawani JP, Manur R et al (2017) Metastatic alveolar soft part sarcoma of the spinal cord: a case report and review of literature. World Neurosurg 103:953e1-953e5
Dickson BC, Chung CT, Hurlbut DJ et al (2020) Genetic diversity in alveolar soft part sarcoma: a subset contain variant fusion genes, highlighting broader molecular kinship with other MiT family tumors. Genes Chromosomes Cancer 59:23–29
Article CAS PubMed Google Scholar
Chai J, Ma J, Liu Y et al (2023) ASPSCR1-TFE3 fusion in a case of Xp11 translocation PEComa of the liver: are ASPSCR1-TFE3 fusion-bearing tumours Xp11 translocation PEComa or alveolar soft part sarcoma? Pathology 55:416–419
Article CAS PubMed Google Scholar
Zhao M, Huang Y, Yin X et al (2023) PEComa with ASPSCR1::TFE3 fusion: expanding the molecular genetic spectrum of TFE3-rearranged PEComa with an emphasis on overlap with alveolar soft part sarcoma. Histopathology. https://doi.org/10.1111/his.15087
Argani P, Wobker SE, Gross JM et al (2022) PEComa-like neoplasms characterized by ASPSCR1-TFE3 fusion: another face of TFE3-related mesenchymal neoplasia. Am J Surg Pathol 46:1153–1159
Article PubMed PubMed Central Google Scholar
Argani P, Gross JM, Baraban E et al (2024) TFE3 -rearranged PEComa/PEComa-like neoplasms : report of 25 new cases expanding the clinicopathologic spectrum and highlighting its association with prior exposure to chemotherapy. Am J Surg Pathol 48:777–789
Bonomo G, Gans A, Mazzapicchi E et al (2023) Sporadic spinal psammomatous malignant melanotic nerve sheath tumor: a case report and literature review. Front Oncol 13:1100532
Article PubMed PubMed Central Google Scholar
Argani P, Antonescu CR, Illei PB et al (2001) Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 159:179–192
Article CAS PubMed PubMed Central Google Scholar
Rodriguez FJ, Folpe AL, Giannini C et al (2012) Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems. Acta Neuropathol 123:295–319
Article PubMed PubMed Central Google Scholar
Williams EA, Ravindranathan A, Gupta R et al (2023) Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs. Neuro Oncol. https://doi.org/10.1093/neuonc/noad179.0633
Article PubMed PubMed Central Google Scholar
Argani P, Aulmann S, Karanjawala Z et al (2009) Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma. Am J Surg Pathol 33:609–619
Kauffman EC, Ricketts CJ, Rais-Bahrami S et al (2014) Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat Rev Urol 11:465–475
Article CAS PubMed PubMed Central Google Scholar
Mitton B, Federman N (2012) Alveolar soft part sarcomas: molecular pathogenesis and implications for novel targeted therapies. Sarcoma 2012:428789
Article PubMed PubMed Central Google Scholar
Schoffski P, Wozniak A, Kasper B et al (2018) Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European organization for research and treatment of cancer (EORTC) phase II trial 90101 ‘CREATE.’ Ann Oncol 29:758–765
Article CAS PubMed Google Scholar
Chi Y, Fang Z, Hong X et al (2018) Safety and efficacy of anlotinib, a multikinase angiogenesis inhibitor, in patients with refractory metastatic soft-tissue sarcoma. Clin Cancer Res 24:5233–5238
Comments (0)